1997
DOI: 10.1016/s0003-4975(97)00213-0
|View full text |Cite
|
Sign up to set email alerts
|

Addition of α-Ketoglutarate to Blood Cardioplegia Improves Cardioprotection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
17
0

Year Published

2003
2003
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 36 publications
(20 citation statements)
references
References 17 publications
3
17
0
Order By: Relevance
“…These data are consistent with other reports indicating that α-ketoglutarate prevents ischemic injury [44,45]. Kjellman et al have argued that improved myocardial protection is the result of provision of α-ketoglutarate, which may preserve cell metabolic state [45]. A low myocardial content of α-ketoglutarate during heart surgery might aggravate ischemic injury [44].…”
Section: Discussionsupporting
confidence: 91%
See 1 more Smart Citation
“…These data are consistent with other reports indicating that α-ketoglutarate prevents ischemic injury [44,45]. Kjellman et al have argued that improved myocardial protection is the result of provision of α-ketoglutarate, which may preserve cell metabolic state [45]. A low myocardial content of α-ketoglutarate during heart surgery might aggravate ischemic injury [44].…”
Section: Discussionsupporting
confidence: 91%
“…It is supposed that the influence of α-ketoglutarate on energy metabolism is realized by cholinesterase inhibition and increase of acetylcholine content [43]. These data are consistent with other reports indicating that α-ketoglutarate prevents ischemic injury [44,45]. Kjellman et al have argued that improved myocardial protection is the result of provision of α-ketoglutarate, which may preserve cell metabolic state [45].…”
Section: Discussionsupporting
confidence: 84%
“…Studies using animal models have shown that dietary supplementation with AKG has favorable effects on energy status, protein synthesis, growth, and performance (Junghans et al, 2006;Hou et al, 2011;Dobrowolski et al, 2013;Yao et al, 2012) and can potentially prevent the development of several systemic diseases commonly found in the elderly (Kjellman et al, 1997;Harisson and Pierzhynowski, 2008;Niemiec et al, 2011;Radzki et al, 2012). Protective properties of AKG were also demonstrated in hyperammonemia, hyperaminoaciduria, or exposures to toxic nitrogen chemicals such as cyanide, ammonia, ammonium compounds, amines and hydrazines (Bhattacharya et al, 2002;Dakshayani et al, 2006;Bhattacharya et al, 2009).…”
Section: Alpha-ketoglutarate (Akg) Is An Important Intermediate In Thmentioning
confidence: 99%
“…Accordingly, the addition of glucose and/or lactate to cardioplegic solutions has no convincing cardioprotective effect (2,11,33,34). Protection by other compounds such as ␣-ketoglutarate (22) and cocarboxylase (23) or by ischemic preconditioning (3) may be more efficient. The addition of adenosine to the cardioplegic solution or for pretreatment has not given conclusive effects so far (28,32,40).…”
mentioning
confidence: 99%